<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>eplerenone</title><link>http://www.unboundmedicine.com/medline/ebm/research/eplerenone</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19875410/full_citation/Timing_of_eplerenone_initiation_and_outcomes_in_patients_with_heart_failure_after_acute_myocardial_infarction_complicated_by_left_ventricular_systolic_dysfunction:_insights_from_the_EPHESUS_trial_</link><description>Adamopoulos C, Ahmed A, Fay R, et al. <br/><span class="title">Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology">Eur J Heart Fail 2009 Nov; 11(11):1099-105.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19875410/abstract/Timing_of_eplerenone_initiation_and_outcomes_in_patients_with_heart_failure_after_acute_myocardial_infarction_complicated_by_left_ventricular_systolic_dysfunction:_insights_from_the_EPHESUS_trial_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19875410/full_citation/Timing_of_eplerenone_initiation_and_outcomes_in_patients_with_heart_failure_after_acute_myocardial_infarction_complicated_by_left_ventricular_systolic_dysfunction:_insights_from_the_EPHESUS_trial_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19875410/Timing_of_eplerenone_initiation_and_outcomes_in_patients_with_heart_failure_after_acute_myocardial_infarction_complicated_by_left_ventricular_systolic_dysfunction:_insights_from_the_EPHESUS_trial_">Find Related Articles</a> </description></item><item><title>Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19865106/full_citation/Clinical_effects_of_eplerenone_a_selective_aldosterone_blocker_in_Japanese_patients_with_essential_hypertension_</link><description>Sato A, Fukuda S <br/><span class="title">Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of human hypertension">J Hum Hypertens 2009 Oct 29.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19865106/abstract/Clinical_effects_of_eplerenone_a_selective_aldosterone_blocker_in_Japanese_patients_with_essential_hypertension_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19865106/full_citation/Clinical_effects_of_eplerenone_a_selective_aldosterone_blocker_in_Japanese_patients_with_essential_hypertension_">Full Citation</a></description></item><item><title>Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19850207/full_citation/Natural_history_of_markers_of_collagen_turnover_in_patients_with_early_diastolic_dysfunction_and_impact_of_eplerenone_</link><description>Mak GJ, Ledwidge MT, Watson CJ, et al. <br/><span class="title">Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone. [Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Journal of the American College of Cardiology">J Am Coll Cardiol 2009 Oct 27; 54(18):1674-82.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19850207/abstract/Natural_history_of_markers_of_collagen_turnover_in_patients_with_early_diastolic_dysfunction_and_impact_of_eplerenone_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19850207/full_citation/Natural_history_of_markers_of_collagen_turnover_in_patients_with_early_diastolic_dysfunction_and_impact_of_eplerenone_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(09)02927-1">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19850207/Natural_history_of_markers_of_collagen_turnover_in_patients_with_early_diastolic_dysfunction_and_impact_of_eplerenone_">Find Related Articles</a> </description></item><item><title>Eplerenone, a selective mineralocorticoid receptor blocker, exerts anxiolytic effects accompanied by changes in stress hormone release.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19825909/full_citation/Eplerenone_a_selective_mineralocorticoid_receptor_blocker_exerts_anxiolytic_effects_accompanied_by_changes_in_stress_hormone_release_</link><description>Hlavacova N, Bakos J, Jezova D <br/><span class="title">Eplerenone, a selective mineralocorticoid receptor blocker, exerts anxiolytic effects accompanied by changes in stress hormone release. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of psychopharmacology (Oxford, England)">J Psychopharmacol 2009 Oct 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19825909/abstract/Eplerenone_a_selective_mineralocorticoid_receptor_blocker_exerts_anxiolytic_effects_accompanied_by_changes_in_stress_hormone_release_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19825909/full_citation/Eplerenone_a_selective_mineralocorticoid_receptor_blocker_exerts_anxiolytic_effects_accompanied_by_changes_in_stress_hormone_release_">Full Citation</a></description></item><item><title>The antiproteinuric effect of the blockage of the renin-angiotensin-aldosterone system (RAAS) in obese patients. Which treatment option is the most effective?</title><link>http://www.unboundmedicine.com/medline/ebm/record/19820754/full_citation/The_antiproteinuric_effect_of_the_blockage_of_the_renin_angiotensin_aldosterone_system__RAAS__in_obese_patients__Which_treatment_option_is_the_most_effective</link><description>Morales E, Huerta A, Gutiérrez E, et al. <br/><span class="title">The antiproteinuric effect of the blockage of the renin-angiotensin-aldosterone system (RAAS) in obese patients. Which treatment option is the most effective? [JOURNAL ARTICLE]</span><br/><span class="source" title="Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia">Nefrologia 2009 Oct; 29(5):421-429.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19820754/abstract/The_antiproteinuric_effect_of_the_blockage_of_the_renin_angiotensin_aldosterone_system__RAAS__in_obese_patients__Which_treatment_option_is_the_most_effective">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19820754/full_citation/The_antiproteinuric_effect_of_the_blockage_of_the_renin_angiotensin_aldosterone_system__RAAS__in_obese_patients__Which_treatment_option_is_the_most_effective">Full Citation</a></description></item><item><title>Establishment of HPLC-ESI-MS method for the determination of eplerenone in human plasma and its pharmacokinetics.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19806919/full_citation/Establishment_of_HPLC_ESI_MS_method_for_the_determination_of_eplerenone_in_human_plasma_and_its_pharmacokinetics_</link><description>Qian WJ, Ding L, Wen AD, et al. <br/><span class="title">Establishment of HPLC-ESI-MS method for the determination of eplerenone in human plasma and its pharmacokinetics. [Journal Article]</span><br/><span class="source" title="Yao xue xue bao = Acta pharmaceutica Sinica">Yao Xue Xue Bao 2009 Jul; 44(7):771-7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19806919/abstract/Establishment_of_HPLC_ESI_MS_method_for_the_determination_of_eplerenone_in_human_plasma_and_its_pharmacokinetics_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19806919/full_citation/Establishment_of_HPLC_ESI_MS_method_for_the_determination_of_eplerenone_in_human_plasma_and_its_pharmacokinetics_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19806919/Establishment_of_HPLC_ESI_MS_method_for_the_determination_of_eplerenone_in_human_plasma_and_its_pharmacokinetics_">Find Related Articles</a> </description></item><item><title>High-salt diet increases plasma adiponectin levels independent of blood pressure in hypertensive rats: the role of the renin-angiotensin-aldosterone system.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19770680/full_citation/High_salt_diet_increases_plasma_adiponectin_levels_independent_of_blood_pressure_in_hypertensive_rats:_the_role_of_the_renin_angiotensin_aldosterone_system_</link><description>Kamari Y, Shimoni N, Koren F, et al. <br/><span class="title">High-salt diet increases plasma adiponectin levels independent of blood pressure in hypertensive rats: the role of the renin-angiotensin-aldosterone system. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of hypertension">J Hypertens 2009 Sep 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19770680/abstract/High_salt_diet_increases_plasma_adiponectin_levels_independent_of_blood_pressure_in_hypertensive_rats:_the_role_of_the_renin_angiotensin_aldosterone_system_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19770680/full_citation/High_salt_diet_increases_plasma_adiponectin_levels_independent_of_blood_pressure_in_hypertensive_rats:_the_role_of_the_renin_angiotensin_aldosterone_system_">Full Citation</a></description></item><item><title>Prevention of atherosclerosis by interference with the vascular nitric oxide system.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19754387/full_citation/Prevention_of_atherosclerosis_by_interference_with_the_vascular_nitric_oxide_system_</link><description>Li H, Förstermann U <br/><span class="title">Prevention of atherosclerosis by interference with the vascular nitric oxide system. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Current pharmaceutical design">Curr Pharm Des 2009; 15(27):3133-45.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19754387/abstract/Prevention_of_atherosclerosis_by_interference_with_the_vascular_nitric_oxide_system_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19754387/full_citation/Prevention_of_atherosclerosis_by_interference_with_the_vascular_nitric_oxide_system_">Full Citation</a></description></item><item><title>Update in primary aldosteronism.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19737921/full_citation/Update_in_primary_aldosteronism_</link><description>Stowasser M <br/><span class="title">Update in primary aldosteronism. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="The Journal of clinical endocrinology and metabolism">J Clin Endocrinol Metab 2009 Oct; 94(10):3623-30.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19737921/abstract/Update_in_primary_aldosteronism_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19737921/full_citation/Update_in_primary_aldosteronism_">Full Citation</a> | <a href="http://jcem.endojournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=19737921">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19737921/Update_in_primary_aldosteronism_">Find Related Articles</a> </description></item><item><title>[Aldosterone antagonists for all patients with heart failure?]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19728679/full_citation/[Aldosterone_antagonists_for_all_patients_with_heart_failure]</link><description>Bauersachs J <br/><span class="title">[Aldosterone antagonists for all patients with heart failure?] [Journal Article]</span><br/><span class="source" title="MMW Fortschritte der Medizin">MMW Fortschr Med 2009 Apr 9; 151(15):33-5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19728679/full_citation/[Aldosterone_antagonists_for_all_patients_with_heart_failure]">Full Citation</a></description></item></channel></rss>